Skip to content

Gilead Sciences GILD Long-Term Debt

Long-Term Debt at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$42.09B-5.3%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$404.3M+36.5%
Precigen logo
PrecigenPGEN
$93.52M
Celcuity logo
CelcuityCELC
$137.87M+30.9%
CG Oncology logo
CG OncologyCGON
$3M
Merck & Co. logo
Merck & Co.MRK
$49.1B+41.1%

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$166.77B+17.4%
Enterprise value$181.31B+12.0%
P/E18.1×-4.4×
P/S5.6×+0.7×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's long-term debt?
Gilead Sciences (GILD) reported long-term debt of $20.86B in Q1 2026.
How has Gilead Sciences's long-term debt changed year-over-year?
Gilead Sciences's long-term debt decreased by 5.8% year-over-year, from $22.15B to $20.86B.
What is the long-term trend for Gilead Sciences's long-term debt?
Over 5 years (2020 to 2025), Gilead Sciences's long-term debt has grown at a -5.0% compound annual growth rate (CAGR), from $28.65B to $22.13B.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.